$OCGN news
The latest OCGN stock news: headlines, filings, AI summaries and sentiment for $OCGN, updated around the clock.
- Ocugen Outlicenses Gene Therapy Candidate OCU400 to Celairis Therapeutics for Asia-Pacific Region
- Ocugen, Inc. - 8-K Filing
- Ocugen Outlines Clinical Milestones for OCU400 and Targets Three BLA Submissions by 2028
- Ocugen Reports Q3 2026 Financial Results and Clinical Pipeline Progress
- Ocugen, Inc. - 10-Q Filing
- Ocugen, Inc. - 8-K Filing
- Ocugen Reports Third Quarter Revenue and EPS Beat
- Ocugen (OCGN) Scheduled to Report Q3 2026 Earnings on November 4
- Ocugen, Inc. - 8-K Filing